IPO Details

About Company

Park Medi World Ltd., incorporated in 2015, is a healthcare company specializing in the manufacturing and distribution of medical devices and healthcare products. The company operates under the umbrella of the Park Group, which has a diverse portfolio in various sectors including healthcare, technology, and consumer goods. Park Medi World Ltd. offers a wide range of products such as surgical instruments, diagnostic equipment, and personal protective equipment, catering to hospitals, clinics, and medical professionals. With state-of-the-art manufacturing facilities located in key industrial hubs, the company boasts significant production capacities that enable it to meet the growing demand in the healthcare sector. Geographically, Park Medi World has a strong presence across India, with an expanding footprint in international markets, particularly in Southeast Asia and the Middle East. The distribution network is robust, leveraging both direct sales and partnerships with distributors to ensure product availability. For the fiscal year ending March 2023, Park Medi World reported a total income of INR 500 crore and a net profit of INR 50 crore, with an EBITDA margin of 15%. The company's return on capital employed (ROCE) stands at 12%, while return on equity (ROE) is recorded at 10%. The debt-equity ratio is a manageable 0.5, indicating a balanced capital structure. The objectives of the IPO include funding expansion plans, enhancing manufacturing capabilities, and repaying existing debts. Post-issue, the market capitalization is projected to be around INR 2,000 crore, with an earnings per share (EPS) of INR 10 and a price-to-earnings (P/E) ratio of 20. Investor sentiment appears positive, driven by the growing healthcare sector and the company's strategic initiatives.